Relapsed / Recurrent Germ Cell Tumors
1 clinical trials · Condition
◉ Watch Relapsed / Recurrent Germ Cell Tumors
| Record | Firm | Date |
|---|---|---|
| A Phase II Study of Sirolimus and Erlotinib in Recurrent/Refractory Germ Cell Tumors (NCT01962896) | Theodore Laetsch | 2014-01-08 |
Track Relapsed / Recurrent Germ Cell Tumors automatically
Every clearance here is in the API, with alerts when new ones post.